Inside AstraZeneca’s abandoned UK vaccine plant deal as Labour and Tories face questions over £450m collapse
AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...
pharmaphorum18h
Daiichi Sankyo partners Alteogen on subcutaneous Enhertu
Daiichi Sankyo has signed a deal worth up to $300 million with South Korean biotech Alteogen to develop a subcutaneous version of its AstraZeneca-partnered cancer drug Enhertu. Alteogen will ...
Scandasia.com10h
AstraZeneca reassures investors as China tax probe impact appears limited
AstraZeneca announced that it could face a fine of up to $4.5 million in China over suspected unpaid import taxes, a figure significantly lower than some investors had feared. The ...
pharmaphorum18h
AstraZeneca leads winners at Reuters Pharma Awards 2022
And the award goes to… The standout winner for Reuter's inaugural European Pharma awards was AstraZeneca (AZ), which took home two trophies. Kicking off the event with a bang, AZ scooped up the ...